Cargando…

Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years — United States, August 13, 2021–August 5, 2022

Detalles Bibliográficos
Autores principales:	Fast, Hannah E., Murthy, Bhavini Patel, Zell, Elizabeth, Meng, Lu, Murthy, Neil, Saelee, Ryan, Lu, Peng-jun, Kang, Yoonjae, Shaw, Lauren, Gibbs-Scharf, Lynn, Harris, LaTreace
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472775/ https://www.ncbi.nlm.nih.gov/pubmed/36048732 http://dx.doi.org/10.15585/mmwr.mm7135a4

Ejemplares similares

Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021
por: Fast, Hannah E., et al.
Publicado: (2021)

Disparities in First Dose COVID-19 Vaccination Coverage among Children 5–11 Years of Age, United States
por: Murthy, Neil Chandra, et al.
Publicado: (2022)

Using a Cloud-Based Machine Learning Classification Tree Analysis to Understand the Demographic Characteristics Associated With COVID-19 Booster Vaccination Among Adults in the United States
por: Meng, Lu, et al.
Publicado: (2022)

Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons >12 Years of Age, United States
por: Meng, Lu, et al.
Publicado: (2022)

COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years — United States, December 14, 2020–July 31, 2021
por: Murthy, Bhavini Patel, et al.
Publicado: (2021)

COVID-19 Vaccination Coverage and Demographic Characteristics of Infants and Children Aged 6 Months–4 Years — United States, June 20–December 31, 2022
por: Murthy, Bhavini Patel, et al.
Publicado: (2023)

COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020–October 2021
por: Murthy, Neil, et al.
Publicado: (2022)

Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–January 31, 2022
por: Saelee, Ryan, et al.
Publicado: (2022)

Minority Health Social Vulnerability Index and COVID-19 vaccination coverage — The United States, December 14, 2020–January 31, 2022
por: Saelee, Ryan, et al.
Publicado: (2023)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
por: Winkler, Erin L., et al.
Publicado: (2023)

Booster performance during the August $\nu$-run: 1975
por: Sacherer, F J
Publicado: (1975)

Booster performance during the August-v-run, 1975
por: Sacherer, F
Publicado: (1975)

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Acute Flaccid Myelitis Among Persons Aged ≤21 Years — United States, August 1–November 13, 2014
Publicado: (2015)

Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program — United States, December 14, 2020–January 14, 2021
por: Painter, Elizabeth M., et al.
Publicado: (2021)

This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination
por: Kantor, Jonathan
Publicado: (2022)

COVID-19 vaccine or booster hesitancy among children aged 6 month-5 years, 5–11 years, and 12–17 years in the United States: An analytic cross-sectional study
por: Park, Chulwoo, et al.
Publicado: (2023)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
por: Voss, Sidsel Skou, et al.
Publicado: (2020)

1080 Antibody Persistence 5 Years After Vaccination at 2 to 10 Years of Age With Quadrivalent MenACWY-CRM Conjugate Vaccine, And Responses To a Booster Vaccination
por: Block, Stanley L., et al.
Publicado: (2014)

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

1157. Immune Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) 5 Years After Primary Vaccination of Adults ≥59 Years of Age
por: Robertson, Corwin A, et al.
Publicado: (2023)

Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
por: Vesikari, Timo, et al.
Publicado: (2020)

Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ≥65 Years — United States, December 14, 2020–April 10, 2021
por: Whiteman, Ari, et al.
Publicado: (2021)

Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
por: Gabutti, Giovanni, et al.
Publicado: (2014)

COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022
por: Johnson, Amelia G., et al.
Publicado: (2023)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study
por: Andersson, Niklas Worm, et al.
Publicado: (2023)

Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
por: Burckhardt, Rachel M., et al.
Publicado: (2022)

PRAC meeting 5 August 2021: COVID-19 vaccine safety issues
Publicado: (2021)

Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children
por: Qiu, Yan, et al.
Publicado: (2022)

Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021
por: Siegel, David A., et al.
Publicado: (2021)

The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China
por: Qin, Chenyuan, et al.
Publicado: (2022)

Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination
por: Diks, Annieck M., et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Administration of Selected Routine Childhood and Adolescent Vaccinations — 10 U.S. Jurisdictions, March–September 2020
por: Patel Murthy, Bhavini, et al.
Publicado: (2021)

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hda5k9a175heq6moj6m93k468r